NCT05687331

Brief Summary

The goal of this observational study is to gain insight in the natural course of pro-inflammatory factors and hemarthrosis in patients older than 18 with a recent knee trauma. The main question\[s\] it aims to answer are:

  • What is the natural course of pro-inflammatory factors and hemarthrosis in knee trauma?
  • What are the effects of inflammation and hemarthrosis on the anti-inflammatory potential of ASC's in order to better determine eligible patients and circumstances for ASC's therapy? Participants will:
  • undergo blood withdrawal
  • undergo knee arthrocentesis for synovial fluid sample collection
  • physical examination
  • fill out a questionnaire on knee complaints

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 18, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

January 18, 2023

Status Verified

December 1, 2022

Enrollment Period

12 months

First QC Date

December 13, 2022

Last Update Submit

January 17, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Synovial fluid analysis

    Analysis of changes in pro-inflammatory factors, erythrocytes (as measurement for hemarthrosis)

    Samples are taken at week 1, week 2, week 4, week 6 and week 8 after trauma

Secondary Outcomes (4)

  • co-culture of synovial fluid with adipose stromal cells

    samples are taken at week 1, week 2, week 4, week 6 and week 8 after trauma

  • MRI-imaging

    At inclusion and 1 year after trauma

  • Physical examination

    Physical examination at week 1, week 2, week 4, week 6 and week 8 after trauma

  • Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire

    Questionnaires are taken at week 1, week 2, week 4, week 6 and week 8 after trauma

Study Arms (2)

Patients with hemarthrosis

10 patients that sustained a knee trauma and have hemarthrosis during knee arthrocentesis (red color of the synovial fluid)

Procedure: knee arthrocentesisProcedure: venipunctureDiagnostic Test: MRI-scanDiagnostic Test: Physical examinationOther: KOOS questionnaire

Patients without hemarthrosis

10 patients that sustained a knee trauma and do not have hemarthrosis during knee arthrocentesis (yellow color of the synovial fluid)

Procedure: knee arthrocentesisProcedure: venipunctureDiagnostic Test: MRI-scanDiagnostic Test: Physical examinationOther: KOOS questionnaire

Interventions

arthrocentesis of the knee joint to gather a synovial fluid sample

Patients with hemarthrosisPatients without hemarthrosis
venipuncturePROCEDURE

Peripheral venipuncture to gather a blood sample

Also known as: blood draw
Patients with hemarthrosisPatients without hemarthrosis
MRI-scanDIAGNOSTIC_TEST

MRI-scan of the knee

Patients with hemarthrosisPatients without hemarthrosis
Physical examinationDIAGNOSTIC_TEST

Physical examination of the injured knee

Patients with hemarthrosisPatients without hemarthrosis

KOOS questionnaire of the injured knee

Patients with hemarthrosisPatients without hemarthrosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients who are presented at the emergency department of the CWZ hospital because of a recent distortion of the knee.

You may qualify if:

  • Recently suffered an injury of the index knee (rotational or hyperextension)
  • A swollen joint
  • Inability to mobilise

You may not qualify if:

  • Patients with an active inflammatory or infectious comorbid disease (including rheumatic diseases)
  • Patients using systemic immunosuppressant medication
  • Patients with a contra-indication for undergoing a MRI-scan (non-compatible implants or claustrophobia for example)
  • Patients with knee prosthesis
  • Patients with coagulation disorders
  • Patients with a history of a cruciate ligament or meniscal injury of the index knee
  • Patients with a tibiofemoral fracture of the index knee due to current distortion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboud umc

Nijmegen, Gelderland, 6525GA, Netherlands

RECRUITING

Related Publications (10)

  • Riordan EA, Little C, Hunter D. Pathogenesis of post-traumatic OA with a view to intervention. Best Pract Res Clin Rheumatol. 2014 Feb;28(1):17-30. doi: 10.1016/j.berh.2014.02.001.

    PMID: 24792943BACKGROUND
  • Lohmander LS, Englund PM, Dahl LL, Roos EM. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am J Sports Med. 2007 Oct;35(10):1756-69. doi: 10.1177/0363546507307396. Epub 2007 Aug 29.

    PMID: 17761605BACKGROUND
  • Luc B, Gribble PA, Pietrosimone BG. Osteoarthritis prevalence following anterior cruciate ligament reconstruction: a systematic review and numbers-needed-to-treat analysis. J Athl Train. 2014 Nov-Dec;49(6):806-19. doi: 10.4085/1062-6050-49.3.35.

    PMID: 25232663BACKGROUND
  • Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005 May;13(5):361-7. doi: 10.1016/j.joca.2005.01.005.

    PMID: 15882559BACKGROUND
  • Pulles AE, Mastbergen SC, Schutgens RE, Lafeber FP, van Vulpen LF. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacol Res. 2017 Jan;115:192-199. doi: 10.1016/j.phrs.2016.11.032. Epub 2016 Nov 24.

    PMID: 27890816BACKGROUND
  • Gupte C, St Mart JP. The acute swollen knee: diagnosis and management. J R Soc Med. 2013 Jul;106(7):259-68. doi: 10.1177/0141076813482831.

    PMID: 23821708BACKGROUND
  • Wang Y, Shimmin A, Ghosh P, Marks P, Linklater J, Connell D, Hall S, Skerrett D, Itescu S, Cicuttini FM. Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial. Arthritis Res Ther. 2017 Aug 2;19(1):180. doi: 10.1186/s13075-017-1391-0.

    PMID: 28768528BACKGROUND
  • ter Huurne M, Schelbergen R, Blattes R, Blom A, de Munter W, Grevers LC, Jeanson J, Noel D, Casteilla L, Jorgensen C, van den Berg W, van Lent PL. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum. 2012 Nov;64(11):3604-13. doi: 10.1002/art.34626.

    PMID: 22961401BACKGROUND
  • Schelbergen RF, van Dalen S, ter Huurne M, Roth J, Vogl T, Noel D, Jorgensen C, van den Berg WB, van de Loo FA, Blom AB, van Lent PL. Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteoarthritis Cartilage. 2014 Aug;22(8):1158-66. doi: 10.1016/j.joca.2014.05.022. Epub 2014 Jun 10.

    PMID: 24928317BACKGROUND
  • Pers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensebe L, Casteilla L, Fleury S, Bourin P, Noel D, Canovas F, Cyteval C, Lisignoli G, Schrauth J, Haddad D, Domergue S, Noeth U, Jorgensen C; ADIPOA Consortium. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial. Stem Cells Transl Med. 2016 Jul;5(7):847-56. doi: 10.5966/sctm.2015-0245. Epub 2016 May 23.

    PMID: 27217345BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood plasma, synovial fluid

MeSH Terms

Conditions

Knee InjuriesHemarthrosis

Interventions

PhlebotomyBlood Specimen CollectionMagnetic Resonance ImagingPhysical Examination

Condition Hierarchy (Ancestors)

Leg InjuriesWounds and InjuriesJoint DiseasesMusculoskeletal DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative TechniquesTomographyDiagnostic Imaging

Central Study Contacts

Bob Evers, Drs/Msc

CONTACT

Rogier Thurlings, Dr/PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2022

First Posted

January 18, 2023

Study Start

April 5, 2022

Primary Completion

April 1, 2023

Study Completion

April 1, 2024

Last Updated

January 18, 2023

Record last verified: 2022-12

Locations